Bilal Arif's most recent trade in KalVista Pharmaceuticals Inc was a trade of 49,000 Restricted Stock Unit done . Disclosure was reported to the exchange on Jan. 16, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| KalVista Pharma Inc | Bilal Arif | Chief Operations Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jan 2026 | 49,000 | 49,000 | - | - | Restricted Stock Unit | |
| KalVista Pharma Inc | Bilal Arif | Chief Operations Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Oct 2025 | 100,000 | 100,000 | - | - | Stock Option (right to buy) | |
| Sarepta Therapeutics Inc | Bilal Arif | Chief Tech Ops Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Aug 2025 | 6,250 | 6,250 | - | - | Performance Stock Units | |
| Sarepta Therapeutics Inc | Bilal Arif | Chief Tech Ops Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2025 | 16,644 | 16,644 | - | - | Stock Options (right to buy) | |
| Sarepta Therapeutics Inc | Bilal Arif | Chief Tech Ops Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2025 | 8,276 | 32,500 (0%) | 0% | - | Common Stock | |
| Sarepta Therapeutics Inc | Bilal Arif | Chief Tech Ops Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 100.13 per share. | 10 Mar 2025 | 523 | 24,224 (0%) | 0% | 100.1 | 52,368 | Common Stock |
| Sarepta Therapeutics Inc | Bilal Arif | Chief Tech Ops Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2025 | 17,500 | 0 | - | - | Performance Stock Units | |
| Sarepta Therapeutics Inc | Bilal Arif | Chief Tech Ops Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2025 | 17,500 | 33,782 (0%) | 0% | - | Common Stock | |
| Sarepta Therapeutics Inc | Bilal Arif | Chief Tech Ops Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 103.70 per share. | 06 Mar 2025 | 8,527 | 24,747 (0%) | 0% | 103.7 | 884,250 | Common Stock |
| Sarepta Therapeutics Inc | Bilal Arif | Chief Tech Ops Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 103.70 per share. | 06 Mar 2025 | 508 | 33,274 (0%) | 0% | 103.7 | 52,680 | Common Stock |
| Sarepta Therapeutics Inc | Bilal Arif | Chief Tech Ops Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 101.34 per share. | 04 Mar 2025 | 281 | 16,515 (0%) | 0% | 101.3 | 28,477 | Common Stock |
| Sarepta Therapeutics Inc | Bilal Arif | Chief Tech Ops Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 101.34 per share. | 04 Mar 2025 | 233 | 16,282 (0%) | 0% | 101.3 | 23,612 | Common Stock |
| Sarepta Therapeutics Inc | Bilal Arif | Chief Tech Ops Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 103.77 per share. | 03 Mar 2025 | 719 | 16,796 (0%) | 0% | 103.8 | 74,611 | Common Stock |
| Sarepta Therapeutics Inc | Bilal Arif | Chief Tech Ops Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 3,500 | 17,500 | - | - | Performance Restricted Stock Units | |
| Sarepta Therapeutics Inc | Bilal Arif | Chief Tech Ops Officer | 21 Jun 2024 | 6,250 | 31,472 (0%) | 0% | - | Common Stock | ||
| Sarepta Therapeutics Inc | Bilal Arif | Chief Tech Ops Officer | 21 Jun 2024 | 6,250 | 0 | - | - | Performance Stock Units | ||
| Sarepta Therapeutics Inc | Bilal Arif | Chief Tech Ops Officer | 21 Jun 2024 | 6,250 | 6,250 | - | - | Performance Stock Units | ||
| Sarepta Therapeutics Inc | Bilal Arif | Chief Tech Ops Officer | 21 Jun 2024 | 5,580 | 23,540 (0%) | 0% | 162.3 | 905,690 | Common Stock | |
| Sarepta Therapeutics Inc | Bilal Arif | Chief Tech Ops Officer | 21 Jun 2024 | 3,898 | 17,363 (0%) | 0% | 163.2 | 636,271 | Common Stock | |
| Sarepta Therapeutics Inc | Bilal Arif | Chief Tech Ops Officer | 21 Jun 2024 | 2,352 | 29,120 (0%) | 0% | 164.6 | 387,233 | Common Stock | |
| Sarepta Therapeutics Inc | Bilal Arif | Chief Tech Ops Officer | 21 Jun 2024 | 1,055 | 22,485 (0%) | 0% | 163.8 | 172,841 | Common Stock | |
| Sarepta Therapeutics Inc | Bilal Arif | Chief Tech Ops Officer | 21 Jun 2024 | 700 | 21,485 (0%) | 0% | 166.1 | 116,270 | Common Stock | |
| Sarepta Therapeutics Inc | Bilal Arif | Chief Tech Ops Officer | 21 Jun 2024 | 300 | 22,185 (0%) | 0% | 164.6 | 49,383 | Common Stock | |
| Sarepta Therapeutics Inc | Bilal Arif | Chief Tech Ops Officer | 21 Jun 2024 | 224 | 21,261 (0%) | 0% | 167.1 | 37,437 | Common Stock | |
| Sarepta Therapeutics Inc | Bilal Arif | Chief Tech Ops Officer | 07 Mar 2024 | 506 | 25,694 (0%) | 0% | 120.5 | 60,968 | Common Stock | |
| Sarepta Therapeutics Inc | Bilal Arif | Chief Tech Ops Officer | 07 Mar 2024 | 472 | 25,222 (0%) | 0% | 123.1 | 58,122 | Common Stock | |
| Sarepta Therapeutics Inc | Bilal Arif | Chief Tech Ops Officer | 04 Mar 2024 | 285 | 26,437 (0%) | 0% | 125.3 | 35,716 | Common Stock | |
| Sarepta Therapeutics Inc | Bilal Arif | Chief Tech Ops Officer | 04 Mar 2024 | 237 | 26,200 (0%) | 0% | 125.3 | 29,701 | Common Stock | |
| Sarepta Therapeutics Inc | Bilal Arif | Chief Tech Ops Officer | 01 Mar 2024 | 12,500 | 12,500 | - | - | Stock Option (right to buy) | ||
| Sarepta Therapeutics Inc | Bilal Arif | Chief Tech Ops Officer | 01 Mar 2024 | 6,000 | 28,836 (0%) | 0% | 0 | Common Stock | ||
| Sarepta Therapeutics Inc | Bilal Arif | Chief Tech Ops Officer | 01 Mar 2024 | 1,543 | 27,293 (0%) | 0% | 128.6 | 198,399 | Common Stock | |
| Sarepta Therapeutics Inc | Bilal Arif | Chief Tech Ops Officer | 01 Mar 2024 | 457 | 26,836 (0%) | 0% | 129.7 | 59,277 | Common Stock | |
| Sarepta Therapeutics Inc | Bilal Arif | Chief Tech Ops Officer | 01 Mar 2024 | 251 | 22,836 (0%) | 0% | 126.2 | 31,674 | Common Stock | |
| Sarepta Therapeutics Inc | Bilal Arif | Chief Tech Ops Officer | 01 Mar 2024 | 114 | 26,722 (0%) | 0% | 126.2 | 14,386 | Common Stock | |
| Sarepta Therapeutics Inc | Arif Bilal | Chief Tech Ops Officer | 01 Dec 2023 | 3,682 | 22,886 (0%) | 0% | 80.3 | 295,812 | Common Stock | |
| Sarepta Therapeutics Inc | Bilal Arif | Chief Tech Ops Officer | 30 Mar 2023 | 307 | 26,367 (0%) | 0% | 136.7 | 41,955 | Common Stock | |
| Sarepta Therapeutics Inc | Bilal Arif | Chief Tech Ops Officer | 08 Mar 2023 | 314 | 26,674 (0%) | 0% | 153.2 | 48,102 | Common Stock | |
| Sarepta Therapeutics Inc | Bilal Arif | Chief Tech Ops Officer | 06 Mar 2023 | 27,000 | 27,000 | - | - | Stock Option (right to buy) | ||
| Sarepta Therapeutics Inc | Bilal Arif | Chief Tech Ops Officer | 06 Mar 2023 | 4,500 | 26,988 (0%) | 0% | 0 | Common Stock | ||
| Sarepta Therapeutics Inc | Bilal Arif | Chief Tech Ops Officer | 06 Mar 2023 | 186 | 22,642 (0%) | 0% | 157.2 | 29,241 | Common Stock | |
| Sarepta Therapeutics Inc | Bilal Arif | Chief Tech Ops Officer | 06 Mar 2023 | 154 | 22,488 (0%) | 0% | 157.2 | 24,210 | Common Stock | |
| Sarepta Therapeutics Inc | Bilal Arif | Chief Tech Ops Officer | 01 Mar 2023 | 172 | 22,828 (0%) | 0% | 147.6 | 25,382 | Common Stock | |
| Sarepta Therapeutics Inc | Bilal Arif | Chief Tech Ops Officer | 01 Mar 2023 | 80 | 22,837 (0%) | 0% | 147.6 | 11,806 | Common Stock | |
| Sarepta Therapeutics Inc | Bilal Arif | Chief Tech Ops Officer | 31 Dec 2022 | 30,000 | 30,000 | - | - | Stock Option (right to buy) |